Article Text

Download PDFPDF
P63 expression in eyelid squamous cell carcinoma
  1. Bita Esmaeli
  1. Ophthalmic Plastic and Orbital Surgery, Department of Plastic Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
  1. Correspondence to Dr Bita Esmaeli, Department of Head and Neck SurOphthalmology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; besmaeli{at}mdanderson.org

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Luo et al report on expression of P63 in 85 patients with periocular and eyelid squamous cell carcinoma (SCC), and observe a correlation with a more advanced T stage and worse disease-specific survival.1 P63 has been previously reported to correlate with poor prognosis in cutaneous and head and neck SCC patients.2 3 The authors also report on Ki67 index in the same cohort of patients with periocular and eyelid SCC; Ki67 is a proliferation index and a higher Ki67 index is generally correlated with a higher mitotic rate and thus an expected worse prognosis across various …

View Full Text

Footnotes

  • Funding The author has not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Commissioned; internally peer reviewed.

Linked Articles